Cardiovascular and metabolic diseases (CVMDs) are a leading cause of
death worldwide and imposes a huge socioeconomic burden on individuals
and healthcare systems, underscoring the urgent need to develop new drug
therapies. Developmental endothelial locus-1 (DEL-1) is a secreted
multifunctional domain protein that can bind to integrins and play an
important role in the occurrence and development of various diseases.
Recently, DEL-1 has attracted great interest for its pharmacological
role in the treatment and/or management of CVMDs. In this review, we
present the current knowledge on the predictive and therapeutic role of
DEL-1 in a variety of CVMDs, such as atherosclerosis, hypertension,
cardiac remodeling, ischemic heart disease, obesity, and insulin
resistance. Collectively, DEL-1 is a promising biomarker and therapeutic
target for CVMDs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.